M R Maniveni Foods IPO Review 2026: GMP, Subscription, Analysis & Listing Outlook

IPO Analysis
M R Maniveni Foods IPO Review 2026: GMP, Subscription, Analysis & Listing Outlook
IPO Analysis26 May 20268 views

M R Maniveni Foods IPO Review 2026: GMP, Subscription, Analysis & Listing Outlook

M R Maniveni Foods IPO shows moderate subscription with flat GMP. Check full review, risks, financials, and listing gain outlook before investing.


M R Maniveni Foods IPO – Complete Analysis

The M R Maniveni Foods Ltd IPO is a ₹27 crore SME issue listed on the BSE SME platform, open from May 22 to May 26, 2026. The IPO has attracted moderate investor interest, but mixed signals from fundamentals, valuation, and GMP suggest a cautious approach.

Particular

Details

IPO Dates

May 22 – May 26, 2026

Listing Date

June 1, 2026 (Tentative)

Issue Size

₹27.04 Cr

Price Band

₹51 – ₹52

Face Value

₹10

Lot Size

2,000 shares

Minimum Investment (Retail)

₹2,08,000

This is a typical SME IPO with high entry cost and limited liquidity post listing.

Business Overview

Established in 2010, the company operates in the pulses processing and trading segment, primarily dealing in:

  • Urad Dal

  • Toor Dal

Core business activities:

  • Sourcing raw pulses

  • Processing (milling & cleaning)

  • Packaging and distribution

  • Serving B2B clients

Business Nature Insight:

  • It is a commodity-based business

  • Margins depend heavily on raw material prices and demand cycles

IPO Structure & Allocation

Category

Shares

% Allocation

QIB

24.52 lakh

47.15%

NII

7.56 lakh

14.54%

Retail

17.32 lakh

33.31%

Market Maker

2.60 lakh

5%

Retail share is relatively high (~33%), which can increase listing volatility.

Subscription Analysis (Final Day)

Final Subscription (May 26, 2026)

  • Overall: ~1.54× – 1.55×

  • Total Applications: ~828–832

Category-wise

Category

Subscription

QIB

1.00×

NII / HNI

~1.77× – 1.81×

Retail

~1.75×

Day-wise Trend (Important Insight)

Day

Total

Retail

NII

QIB

Day 1

1.09×

0.89×

1.66×

1.00×

Day 2

1.39×

1.53×

1.57×

1.00×

Final Day

1.54×

1.75×

1.77×

1.00×

What this tells us:

  • No strong last-day rush → weak momentum

  • Subscription stayed below 2× → average demand

  • QIBs didn't increase beyond anchor → low institutional conviction


GMP (Grey Market Premium) Analysis

Although exact GMP data isn’t provided, based on:

  • Subscription (~1.5×)

  • SME segment behavior

  • Weak QIB demand

Expected GMP Scenario:

  • Likely ₹0 to ₹5 (flat/low premium)

  • Listing could be:

    • Near issue price

    • Slight premium or flat

Interpretation:

  • Market sentiment is neutral

  • No strong listing gains expected

Financial Performance

Key Financials (₹ Crore)

Metric

FY25

FY24

FY23

Revenue

203.52

155.00

119.61

PAT

4.13

2.18

1.56

EBITDA

7.82

5.05

3.72

Revenue growth is good.
Profit margins are low.

Key Ratios

Ratio

Value

ROE

~26.67%

ROCE

~17.14%

Debt/Equity

~1.10

PAT Margin

~2%

EBITDA Margin

~3–5%

P/E (Post IPO)

~22.87

  • Good growth, but low profitability

  • Margins are very thin, typical of commodity businesses

  • Valuation looks expensive for its segment

IPO Objectives (Use of Funds)

Purpose

Amount

Factory Construction

₹12.69 Cr

Machinery Purchase

₹13.61 Cr

General Corporate

Balance

Positive: Funds used for expansion
No debt reduction → leverage remains


Strengths vs Risks

✅ Strengths

  • Established business (since 2010)

  • Growing revenue trend

  • Anchor investor participation

  • Scalable operations

❌ Key Risks

  • Very low margins (2% PAT)

  • Commodity business → price volatility risk

  • High competition from unorganized players

  • Debt level is moderate-high

  • SME listing → low liquidity risk

  • Weak QIB participation

Expert & Market View

  • IPO seen as aggressively priced

  • Industry does not justify high valuation multiples

  • Lead manager track record not strong

  • Many analysts suggest: "Avoid / Skip"

IPO Lifecycle Summary

Stage

Date

IPO Open

May 22

IPO Close

May 26

Allotment

May 27

Refunds

May 29

Shares Credit

May 29

Listing

June 1

Investment Verdict

Listing Gain View

  • Moderate subscription supports listing

  • No strong momentum or GMP
    Expected Listing: Flat to small gain (~0–10%)

Long-Term View

  • Weak margins

  • Competitive industry
    Not ideal for long-term investors

Final Recommendation

Investor Type

Strategy

Conservative

❌ Avoid

Listing Gain Focus

⚠️ Apply with caution

Long-term Investor

❌ Skip

The M R Maniveni Foods IPO is a low-to-average quality SME IPO with:

  • Decent subscription (~1.5×)

  • Weak institutional demand

  • Low-margin business

  • Aggressive pricing

Overall, it lacks strong triggers for high listing gains or long-term growth.

Comments

No comments yet

Be the first to share your thoughts!